LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today announced that Vivid Sehgal, Chief Financial Officer of LivaNova, will be presenting at the Berenberg European Conference in the United Kingdom on Wednesday, December 7, 2016 at 9:45 a.m.

About LivaNova

LivaNova PLC is a global medical technology company formed by the merger of Sorin S.p.A, a leader in the treatment of cardiovascular diseases, and Cyberonics Inc., a medical device company with core expertise in neuromodulation. LivaNova transforms medical innovation into meaningful solutions for the benefit of patients, healthcare professionals, and healthcare systems.

The Company employs approximately 4,600 employees worldwide and is headquartered in London, U.K.

For more information, please visit www.livanova.com.

LivaNova PLCInvestor Relations and MediaKaren King, +1 (281) 228-7262Vice President, Investor Relations & Corporate CommunicationsFax: +1 (281) 218-9332corporate.communications@livanova.com

Livanova (LSE:LIVN)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Livanova Charts.
Livanova (LSE:LIVN)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Livanova Charts.